Showing results (41-50 of 703) with videos related to
Sort By:
Pageof 71
Antimicrobial Agents and Chemotherapy|March 18, 2000
Effect of fluconazole on the pharmacokinetics of doxorubicin in nonhuman primatesK E Warren, C M McCully, T J Walsh, et al.Pediatric Clinics of North America|April 1, 1991
Principles of treatment of pediatric solid tumorsS L Berg, D L Grisell, T F DeLaney, et al.Antimicrobial Agents and Chemotherapy|June 1, 1989
Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeysF M Balis, C McCully, L Gough, et al.Analytical Biochemistry|January 1, 1997
Fluorescence properties of pteridine nucleoside analogs as monomers and incorporated into oligonucleotidesM E Hawkins, W Pfleiderer, F M Balis, et al.Nucleic Acids Research|August 11, 1995
Incorporation of a fluorescent guanosine analog into oligonucleotides and its application to a real time assay for the HIV-1 integrase 3'-processing reactionM E Hawkins, W Pfleiderer, A Mazumder, et al.Analytical Biochemistry|June 28, 2000
Real-time fluorescence assay for O6-alkylguanine-DNA alkyltransferaseA M Moser, M Patel, H Yoo, et al.Journal of the National Cancer Institute|September 20, 2001
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumorsK E Warren, N Patronas, A A Aikin, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 28, 2018
A validated HPLC-MS/MS method for estimating the concentration of the ganglioside, GD2, in human plasma or serumC M Busch, A V Desai, G S Moorthy, et al.Cancer Chemotherapy and Pharmacology|November 7, 1999
The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate modelB C Widemann, F M Balis, K S Godwin, et al.Cancer Research|October 1, 1994
A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluidC Sung, S M Blaney, D E Cole, et al.Pageof 71